ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial ...
Producing high levels of valuable medicinal compounds in plants has long been limited by the difficulty of precisely ...
The idea of self-amplifying gene editing is to get cells to pass on packages of CRISPR machinery to their neighbours, ...
Researchers used CRISPR gene editing to selectively kill cancer cells with amplified oncogenes. In animal and cellular models ...
For most of his 20 years, a New Jersey man knew pain as a daily reality. Now, after a one-time CRISPR gene-editing treatment at Children's Hospital of Philadelphia, Austin Louis says he is finally ...
The onset and aggressiveness of cancer are related to the abnormal behavior of certain genes, known as oncogenes. The best-known of these alterations is mutation, but it is not the only one. Sometimes ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the fourth quarter and ...
Richmond Pharmacology, a leading clinical research organisation specialising in early-phase and innovative clinical trials, today announced the establishment of its Expert Regulatory Advisory Board ...
In conjunction with National Inventors Day today, the National Inventors Hall of Fame® is proud to recognize 15 innovation ...
News Medical on MSN
Engineered wax moths offer ethical alternative to rodents used in research
A scientific breakthrough not only promises faster testing for antimicrobial resistance, but also an ethical solution to the controversial issue of using rodents in research. University of Exeter ...
CRISPR Therapeutics (NASDAQ:CRSP) is one of the stocks that should double by 2030. On January 30, Citizens maintained an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results